Complete financial analysis of Novartis India Limited (NOVARTIND.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Novartis India Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Frazier Lifesciences Acquisition Corporation (FLAC) Income Statement Analysis – Financial Results
- LiveTiles Limited (LVTSF) Income Statement Analysis – Financial Results
- Vitro, S.A.B. de C.V. (VITROA.MX) Income Statement Analysis – Financial Results
- In Win Development Inc. (6117.TW) Income Statement Analysis – Financial Results
- Shandong Donghong Pipe Industry Co., Ltd. (603856.SS) Income Statement Analysis – Financial Results
Novartis India Limited (NOVARTIND.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.novartis.in
About Novartis India Limited
Novartis India Limited operates as a healthcare company in India. It offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands; and neurosciences products under the Tegrital and Exelon brands. The company was incorporated in 1947 and is based in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.35B | 3.69B | 3.88B | 3.66B | 4.11B | 4.50B | 5.17B | 6.10B | 6.90B | 8.73B | 8.62B | 9.03B | 8.44B | 7.51B | 6.24B | 5.99B | 5.53B |
| Cost of Revenue | 2.02B | 2.05B | 1.81B | 1.50B | 1.85B | 2.02B | 2.50B | 3.11B | 2.91B | 3.58B | 3.93B | 3.72B | 3.11B | 2.75B | 2.51B | 2.52B | 2.46B |
| Gross Profit | 1.33B | 1.64B | 2.06B | 2.16B | 2.26B | 2.48B | 2.67B | 2.98B | 3.98B | 5.16B | 4.69B | 5.32B | 5.33B | 4.76B | 3.73B | 3.47B | 3.08B |
| Gross Profit Ratio | 39.60% | 44.56% | 53.17% | 59.07% | 54.94% | 55.12% | 51.71% | 48.91% | 57.74% | 59.05% | 54.41% | 58.86% | 63.11% | 63.33% | 59.74% | 57.89% | 55.63% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 67.80M | 64.20M | 79.50M | 64.10M | 86.50M | 119.60M | 105.50M | 112.40M | 102.20M | 85.60M | 0.00 | 103.30M | 397.90M | 323.00M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 158.70M | 279.80M | 356.60M | 397.70M | 539.90M | 602.90M | 724.80M | 758.30M | 707.40M | 786.30M | 0.00 | 906.80M | 931.50M | 821.80M | 0.00 | 0.00 | 0.00 |
| SG&A | 226.50M | 344.00M | 436.10M | 461.80M | 626.40M | 722.50M | 830.30M | 870.70M | 809.60M | 871.90M | 1.47B | 3.85B | 1.33B | 1.14B | 0.00 | 0.00 | 0.00 |
| Other Expenses | 1.09B | 7.20M | 63.80M | 40.40M | 2.10M | 100.00K | 31.10M | 59.90M | 46.60M | 71.60M | 66.40M | 59.30M | 67.50M | 24.40M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.32B | 1.04B | 1.89B | 2.01B | 2.25B | 2.35B | 2.74B | 2.76B | 3.63B | 5.01B | 4.67B | 4.43B | 3.88B | 2.93B | 1.94B | 1.83B | 1.63B |
| Cost & Expenses | 2.69B | 3.09B | 3.70B | 3.51B | 4.10B | 4.37B | 5.24B | 5.87B | 6.55B | 8.59B | 8.60B | 8.14B | 6.99B | 5.69B | 4.45B | 4.35B | 4.08B |
| Interest Income | 553.40M | 545.00M | 212.30M | 244.50M | 359.30M | 470.30M | 1.47B | 632.50M | 727.90M | 796.50M | 810.90M | 744.60M | 729.30M | 522.50M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 14.90M | 17.50M | 48.30M | 76.80M | 63.90M | 15.90M | 55.30M | 7.20M | 2.10M | 106.30M | 100.00K | 2.20M | 5.40M | 2.80M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 26.10M | 60.60M | 96.50M | 121.60M | 131.40M | 31.80M | 25.30M | 35.90M | 34.90M | 40.10M | 36.50M | 35.90M | 26.70M | 23.80M | 22.51M | 26.88M | 28.50M |
| EBITDA | 1.27B | 1.23B | 106.60M | 598.80M | 481.70M | 905.40M | 1.60B | 953.20M | 1.17B | 158.40M | 951.40M | 976.60M | 1.48B | 2.22B | 1.81B | 1.67B | 1.48B |
| EBITDA Ratio | 37.88% | 32.69% | 14.10% | 15.15% | 11.79% | 13.27% | 28.17% | 15.74% | 16.72% | 1.81% | 8.46% | 10.27% | 17.50% | 29.46% | 29.03% | 27.85% | 26.75% |
| Operating Income | 626.50M | 676.60M | 183.80M | 166.60M | 30.20M | 147.70M | -44.60M | 249.30M | 353.30M | 118.30M | 693.20M | 891.40M | 1.45B | 2.19B | 1.79B | 1.64B | 1.45B |
| Operating Income Ratio | 18.70% | 18.33% | 4.74% | 4.56% | 0.73% | 3.28% | -0.86% | 4.09% | 5.12% | 1.35% | 8.04% | 9.87% | 17.18% | 29.14% | 28.67% | 27.40% | 26.23% |
| Total Other Income/Expenses | 601.90M | 477.20M | -275.90M | 233.80M | 273.50M | 725.10M | 1.62B | 675.30M | 764.60M | 800.30M | 5.40M | 993.60M | 796.40M | 363.70M | 8.73M | 35.38M | 48.29M |
| Income Before Tax | 1.23B | 1.15B | -38.20M | 400.40M | 286.40M | 857.70M | 1.58B | 917.30M | 1.11B | 918.60M | 698.60M | 1.69B | 2.25B | 2.19B | 1.80B | 1.73B | 1.54B |
| Income Before Tax Ratio | 36.66% | 31.26% | -0.99% | 10.95% | 6.96% | 19.05% | 30.46% | 15.05% | 16.15% | 10.52% | 8.10% | 18.75% | 26.61% | 29.14% | 28.81% | 28.84% | 27.88% |
| Income Tax Expense | 376.50M | 120.20M | -1.00M | 191.40M | 185.60M | 340.00M | 791.60M | 345.10M | 388.80M | 125.30M | -158.80M | 496.90M | 726.70M | 722.40M | 638.11M | 692.02M | 570.79M |
| Net Income | 851.90M | 1.03B | -37.20M | 209.00M | 100.80M | 517.70M | 783.60M | 572.20M | 1.98B | 791.10M | 985.30M | 1.20B | 1.52B | 1.47B | 1.16B | 1.04B | 972.35M |
| Net Income Ratio | 25.42% | 28.00% | -0.96% | 5.72% | 2.45% | 11.50% | 15.15% | 9.39% | 28.75% | 9.06% | 11.43% | 13.25% | 18.01% | 19.52% | 18.58% | 17.30% | 17.57% |
| EPS | 34.50 | 41.86 | -1.51 | 8.46 | 4.08 | 20.97 | 28.43 | 19.10 | 62.04 | 0.25 | 30.83 | 37.46 | 47.56 | 45.89 | 36.29 | 32.45 | 30.42 |
| EPS Diluted | 34.50 | 41.86 | -1.51 | 8.46 | 4.08 | 20.97 | 28.43 | 19.10 | 62.04 | 0.25 | 30.83 | 37.46 | 47.56 | 45.89 | 36.29 | 32.45 | 30.42 |
| Weighted Avg Shares Out | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 27.56M | 29.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M |
| Weighted Avg Shares Out (Dil) | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 24.69M | 27.56M | 29.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M | 31.96M |
Source: https://incomestatements.info
Category: Stock Reports